JOHN KIRKWOOD to Thyroid Neoplasms
This is a "connection" page, showing publications JOHN KIRKWOOD has written about Thyroid Neoplasms.
Connection Strength
0.102
-
Clinical Development of BRAF plus MEK Inhibitor Combinations. Trends Cancer. 2020 09; 6(9):797-810.
Score: 0.082
-
Phase II study of etoposide (VP-16) in patients with thyroid cancer with no prior chemotherapy: an Eastern Cooperative Oncology Group Study (E1385). Med Oncol. 2000 Feb; 17(1):47-51.
Score: 0.020